EddingGenor Pharmaceutical Group

EddingGenor Pharmaceutical Group is a leading integrated biopharmaceutical company formed through the landmark reverse merger of Edding Group (Eddingpharm) and Genor Biopharma. The company combines Eddingpharm's robust commercial platform and specialty medicine portfolio with Genor Biopharma's innovative biologics R&D capabilities. Its business spans the entire value chain, from drug discovery and clinical development to large-scale manufacturing and commercialization. EddingGenor focuses on high-growth therapeutic areas including oncology, autoimmune diseases, respiratory, and cardiovascular health. With a strong presence in the Chinese market and a growing international footprint, the group aims to deliver high-quality, affordable innovative therapies to patients globally.